Publication digests
Take a deep dive into cutting-edge food allergy research with our publication digests.
- Explore data from recent clinical trials to help inform your clinical practice
- Learn more about the efficacy and safety of oral immunotherapy (OIT) in children
- Improve your understanding of multiple food allergen oral immunotherapy (mOIT)
- Discover the efficacy, safety and cost-effectiveness of allergen-specific immunotherapy to treat food allergy
The IMPACT trial
Summarised below, the Immune Tolerance Network IMPACT trial was designed to investigate the efficacy and safety of oral immunotherapy in peanut-allergic children aged 1–3 years.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Transitioning novel food allergy tests into clinical practice: a clinical commentary review
This infographic summarises three novel food allergy tests (bead-based epitope assay, basophil activation test and mast cell activation test), their potential applications and the steps needed before they may be implemented into clinical practice.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Allergen immunotherapy and/or biologicals for IgE-mediated food allergy
This infographic summarises the findings from a systematic review and meta-analysis that aimed to understand the efficacy, safety and cost-effectiveness of allergen-specific immunotherapy (AIT) and biologicals to treat immunoglobin E (IgE)-mediated food allergies.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
of interest
are looking at
saved
next event
This content has been developed independently of the sponsor, Novartis Pharma AG, who has had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.